_id
691720643c536f8df2316891
Ticker
TOI
Name
Oncology Institute Inc
Exchange
NASDAQ
Address
18000 Studebaker Road, Cerritos, CA, United States, 90703
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://theoncologyinstitute.com
Description
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Last Close
3.76
Volume
1722406
Current Price
3.78
Change
0.5319148936170218
Last Updated
2025-12-04T14:18:51.555Z
Image
https://logo.clearbit.com/theoncologyinstitute.com
Ipo Date
2021-11-15T00:00:00.000Z
Market Cap
287994688
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.984775
Sentiment Sources
20
Rating
5
Target Price
7
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
136564000
Cost Of Revenue
117644000
Gross Profit
18920000
Operating Expenses
26974000
Operating Income
-8054000
Interest Expense
1920000
Pretax Income
-16504000
Net Income
-16504000
Eps
-0.016931556164205195
Dividends Per Share
-
Shares Outstanding
93504767
Income Tax Expense
-
EBITDA
-12861000
Operating Margin
-5.897601124747371
Total Other Income Expense Net
-8450000
Cash
27658000
Short Term Investments
-
Receivables
59978000
Inventories
18882000
Total Current Assets
110092000
Property Plant Equipment
33979000
Total Assets
163619000
Payables
35634000
Short Term Debt
7161000
Long Term Debt
76195000
Total Liabilities
175893000
Equity
-12274000
Depreciation
1723000
Change In Working Capital
-6172000
Cash From Operations
-12630000
Capital Expenditures
604000
Cash From Investing
-604000
Cash From Financing
10600000
Net Change In Cash
-2634000
PE
-
PB
-300.1912438161968
ROE
134.46309271631088
ROA
-10.086848104437749
FCF
-13234000
Fcf Percent
-0.09690694472921121
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
136564000
Quarters > 0 > income Statement > cost Of Revenue
117644000
Quarters > 0 > income Statement > gross Profit
18920000
Quarters > 0 > income Statement > operating Expenses
26974000
Quarters > 0 > income Statement > operating Income
-8054000
Quarters > 0 > income Statement > interest Expense
1920000
Quarters > 0 > income Statement > pretax Income
-16504000
Quarters > 0 > income Statement > net Income
-16504000
Quarters > 0 > income Statement > eps
-0.016931556164205195
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
974747970
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-12861000
Quarters > 0 > income Statement > operating Margin
-5.897601124747371
Quarters > 0 > income Statement > total Other Income Expense Net
-8450000
Quarters > 0 > balance Sheet > cash
27658000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
59978000
Quarters > 0 > balance Sheet > inventories
18882000
Quarters > 0 > balance Sheet > total Current Assets
110092000
Quarters > 0 > balance Sheet > property Plant Equipment
33979000
Quarters > 0 > balance Sheet > total Assets
163619000
Quarters > 0 > balance Sheet > payables
35634000
Quarters > 0 > balance Sheet > short Term Debt
7161000
Quarters > 0 > balance Sheet > long Term Debt
76195000
Quarters > 0 > balance Sheet > total Liabilities
175893000
Quarters > 0 > balance Sheet > equity
-12274000
Quarters > 0 > cash Flow > net Income
-16504000
Quarters > 0 > cash Flow > depreciation
1723000
Quarters > 0 > cash Flow > change In Working Capital
-6172000
Quarters > 0 > cash Flow > cash From Operations
-12630000
Quarters > 0 > cash Flow > capital Expenditures
604000
Quarters > 0 > cash Flow > cash From Investing
-604000
Quarters > 0 > cash Flow > cash From Financing
10600000
Quarters > 0 > cash Flow > net Change In Cash
-2634000
Quarters > 0 > ratios > PE
-0.016931556164205195
Quarters > 0 > ratios > PB
-300.1912438161968
Quarters > 0 > ratios > ROE
134.46309271631088
Quarters > 0 > ratios > ROA
-10.086848104437749
Quarters > 0 > ratios > FCF
-13234000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.09690694472921121
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
119802000
Quarters > 1 > income Statement > cost Of Revenue
102301000
Quarters > 1 > income Statement > gross Profit
17501000
Quarters > 1 > income Statement > operating Expenses
28712000
Quarters > 1 > income Statement > operating Income
-11211000
Quarters > 1 > income Statement > interest Expense
1870000
Quarters > 1 > income Statement > pretax Income
-17140000
Quarters > 1 > income Statement > net Income
-17009000
Quarters > 1 > income Statement > eps
-0.01824928236459371
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
932036650
Quarters > 1 > income Statement > income Tax Expense
-131000
Quarters > 1 > income Statement > EBITDA
-9406000
Quarters > 1 > income Statement > operating Margin
-9.35794060199329
Quarters > 1 > income Statement > total Other Income Expense Net
-5929000
Quarters > 1 > balance Sheet > cash
30292000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
55659000
Quarters > 1 > balance Sheet > inventories
15786000
Quarters > 1 > balance Sheet > total Current Assets
104792000
Quarters > 1 > balance Sheet > property Plant Equipment
34741000
Quarters > 1 > balance Sheet > total Assets
159798000
Quarters > 1 > balance Sheet > payables
34933000
Quarters > 1 > balance Sheet > short Term Debt
7303000
Quarters > 1 > balance Sheet > long Term Debt
75023000
Quarters > 1 > balance Sheet > total Liabilities
168783000
Quarters > 1 > balance Sheet > equity
-8985000
Quarters > 1 > cash Flow > net Income
-13991000
Quarters > 1 > cash Flow > depreciation
1805000
Quarters > 1 > cash Flow > change In Working Capital
-3285000
Quarters > 1 > cash Flow > cash From Operations
-10202000
Quarters > 1 > cash Flow > capital Expenditures
1208000
Quarters > 1 > cash Flow > cash From Investing
-1208000
Quarters > 1 > cash Flow > cash From Financing
1963000
Quarters > 1 > cash Flow > net Change In Cash
-9447000
Quarters > 1 > ratios > PE
-0.01824928236459371
Quarters > 1 > ratios > PB
-392.10890784641066
Quarters > 1 > ratios > ROE
189.3043962159154
Quarters > 1 > ratios > ROA
-10.644063129701248
Quarters > 1 > ratios > FCF
-11410000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.09524048012554047
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
104406000
Quarters > 2 > income Statement > cost Of Revenue
87157000
Quarters > 2 > income Statement > gross Profit
17249000
Quarters > 2 > income Statement > operating Expenses
27160000
Quarters > 2 > income Statement > operating Income
-9911000
Quarters > 2 > income Statement > interest Expense
5570000
Quarters > 2 > income Statement > pretax Income
-19585000
Quarters > 2 > income Statement > net Income
-19585000
Quarters > 2 > income Statement > eps
-0.2540240470045007
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
77099000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-12231000
Quarters > 2 > income Statement > operating Margin
-9.492749458843361
Quarters > 2 > income Statement > total Other Income Expense Net
-9674000
Quarters > 2 > balance Sheet > cash
39739000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
49666000
Quarters > 2 > balance Sheet > inventories
12308000
Quarters > 2 > balance Sheet > total Current Assets
106820000
Quarters > 2 > balance Sheet > property Plant Equipment
35325000
Quarters > 2 > balance Sheet > total Assets
164002000
Quarters > 2 > balance Sheet > payables
29291000
Quarters > 2 > balance Sheet > short Term Debt
6816000
Quarters > 2 > balance Sheet > long Term Debt
73894000
Quarters > 2 > balance Sheet > total Liabilities
158933000
Quarters > 2 > balance Sheet > equity
5069000
Quarters > 2 > cash Flow > net Income
-19585000
Quarters > 2 > cash Flow > depreciation
1784000
Quarters > 2 > cash Flow > change In Working Capital
3129000
Quarters > 2 > cash Flow > cash From Operations
-4988000
Quarters > 2 > cash Flow > capital Expenditures
328000
Quarters > 2 > cash Flow > cash From Investing
-202000
Quarters > 2 > cash Flow > cash From Financing
-4740000
Quarters > 2 > cash Flow > net Change In Cash
-9930000
Quarters > 2 > ratios > PE
-0.2540240470045007
Quarters > 2 > ratios > PB
57.49343460248569
Quarters > 2 > ratios > ROE
-386.3681199447623
Quarters > 2 > ratios > ROA
-11.941927537469056
Quarters > 2 > ratios > FCF
-5316000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.05091661398770186
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
100267000
Quarters > 3 > income Statement > cost Of Revenue
85631000
Quarters > 3 > income Statement > gross Profit
14636000
Quarters > 3 > income Statement > operating Expenses
26565000
Quarters > 3 > income Statement > operating Income
-11929000
Quarters > 3 > income Statement > interest Expense
1168000
Quarters > 3 > income Statement > pretax Income
-13182000
Quarters > 3 > income Statement > net Income
-13182000
Quarters > 3 > income Statement > eps
-0.17423778667730194
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
75655231
Quarters > 3 > income Statement > income Tax Expense
3617001
Quarters > 3 > income Statement > EBITDA
-10307000
Quarters > 3 > income Statement > operating Margin
-11.897234384194201
Quarters > 3 > income Statement > total Other Income Expense Net
-1253000
Quarters > 3 > balance Sheet > cash
49669000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
48681000
Quarters > 3 > balance Sheet > inventories
10039000
Quarters > 3 > balance Sheet > total Current Assets
112418000
Quarters > 3 > balance Sheet > property Plant Equipment
37670000
Quarters > 3 > balance Sheet > total Assets
172717000
Quarters > 3 > balance Sheet > payables
24324000
Quarters > 3 > balance Sheet > short Term Debt
6798000
Quarters > 3 > balance Sheet > long Term Debt
93131000
Quarters > 3 > balance Sheet > total Liabilities
169128000
Quarters > 3 > balance Sheet > equity
3589000
Quarters > 3 > cash Flow > net Income
-13182000
Quarters > 3 > cash Flow > depreciation
1707000
Quarters > 3 > cash Flow > change In Working Capital
12734000
Quarters > 3 > cash Flow > cash From Operations
4186000
Quarters > 3 > cash Flow > capital Expenditures
1755000
Quarters > 3 > cash Flow > cash From Investing
-1755000
Quarters > 3 > cash Flow > cash From Financing
-164000
Quarters > 3 > cash Flow > net Change In Cash
2267000
Quarters > 3 > ratios > PE
-0.17423778667730194
Quarters > 3 > ratios > PB
79.68146368904986
Quarters > 3 > ratios > ROE
-367.28893842295906
Quarters > 3 > ratios > ROA
-7.632138121898829
Quarters > 3 > ratios > FCF
2431000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.02424526514207067
Quarters > 3 > health Score
10
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
393412000
Annuals > 0 > income Statement > cost Of Revenue
339415000
Annuals > 0 > income Statement > gross Profit
53997000
Annuals > 0 > income Statement > operating Expenses
114115000
Annuals > 0 > income Statement > operating Income
-60118000
Annuals > 0 > income Statement > interest Expense
7496000
Annuals > 0 > income Statement > pretax Income
-64663000
Annuals > 0 > income Statement > net Income
-64663000
Annuals > 0 > income Statement > eps
-0.8616715188186805
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
75043678
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-53831000
Annuals > 0 > income Statement > operating Margin
-15.281181051925207
Annuals > 0 > income Statement > total Other Income Expense Net
-4545000
Annuals > 0 > balance Sheet > cash
49669000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
48681000
Annuals > 0 > balance Sheet > inventories
10039000
Annuals > 0 > balance Sheet > total Current Assets
112418000
Annuals > 0 > balance Sheet > property Plant Equipment
37670000
Annuals > 0 > balance Sheet > total Assets
172717000
Annuals > 0 > balance Sheet > payables
24324000
Annuals > 0 > balance Sheet > short Term Debt
6798000
Annuals > 0 > balance Sheet > long Term Debt
93131000
Annuals > 0 > balance Sheet > total Liabilities
169128000
Annuals > 0 > balance Sheet > equity
3589000
Annuals > 0 > cash Flow > net Income
-53005000
Annuals > 0 > cash Flow > depreciation
6287000
Annuals > 0 > cash Flow > change In Working Capital
18059000
Annuals > 0 > cash Flow > cash From Operations
-26538000
Annuals > 0 > cash Flow > capital Expenditures
3789000
Annuals > 0 > cash Flow > cash From Investing
46211000
Annuals > 0 > cash Flow > cash From Financing
-3492000
Annuals > 0 > cash Flow > net Change In Cash
16181000
Annuals > 0 > ratios > PE
-0.8616715188186805
Annuals > 0 > ratios > PB
64.19172233491223
Annuals > 0 > ratios > ROE
-1801.699637782112
Annuals > 0 > ratios > ROA
-37.43870030164952
Annuals > 0 > ratios > FCF
-30327000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.07708712494789177
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
324239000
Annuals > 1 > income Statement > cost Of Revenue
264666000
Annuals > 1 > income Statement > gross Profit
59573000
Annuals > 1 > income Statement > operating Expenses
136591000
Annuals > 1 > income Statement > operating Income
-77018000
Annuals > 1 > income Statement > interest Expense
6777000
Annuals > 1 > income Statement > pretax Income
-83104000
Annuals > 1 > income Statement > net Income
-83068000
Annuals > 1 > income Statement > eps
-1.1263662282135025
Annuals > 1 > income Statement > dividends Per Share
1
Annuals > 1 > income Statement > shares Outstanding
73748660
Annuals > 1 > income Statement > income Tax Expense
-36000
Annuals > 1 > income Statement > EBITDA
-54278000
Annuals > 1 > income Statement > operating Margin
-23.753465807629556
Annuals > 1 > income Statement > total Other Income Expense Net
-6086000
Annuals > 1 > balance Sheet > cash
33488000
Annuals > 1 > balance Sheet > short Term Investments
49367000
Annuals > 1 > balance Sheet > receivables
42911000
Annuals > 1 > balance Sheet > inventories
13678000
Annuals > 1 > balance Sheet > total Current Assets
143493000
Annuals > 1 > balance Sheet > property Plant Equipment
40052000
Annuals > 1 > balance Sheet > total Assets
209240000
Annuals > 1 > balance Sheet > payables
14429000
Annuals > 1 > balance Sheet > short Term Debt
6363000
Annuals > 1 > balance Sheet > long Term Debt
86826000
Annuals > 1 > balance Sheet > total Liabilities
152215000
Annuals > 1 > balance Sheet > equity
57025000
Annuals > 1 > cash Flow > net Income
-83068000
Annuals > 1 > cash Flow > depreciation
5873000
Annuals > 1 > cash Flow > change In Working Capital
2359000
Annuals > 1 > cash Flow > cash From Operations
-36315000
Annuals > 1 > cash Flow > capital Expenditures
4567000
Annuals > 1 > cash Flow > cash From Investing
62640000
Annuals > 1 > cash Flow > cash From Financing
-6847000
Annuals > 1 > cash Flow > net Change In Cash
19478000
Annuals > 1 > ratios > PE
-1.1263662282135025
Annuals > 1 > ratios > PB
3.9703355756247256
Annuals > 1 > ratios > ROE
-145.66944322665498
Annuals > 1 > ratios > ROA
-39.69986618237431
Annuals > 1 > ratios > FCF
-40882000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.12608600445967327
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
252483000
Annuals > 2 > income Statement > cost Of Revenue
200390000
Annuals > 2 > income Statement > gross Profit
52093000
Annuals > 2 > income Statement > operating Expenses
134044000
Annuals > 2 > income Statement > operating Income
-81951000
Annuals > 2 > income Statement > interest Expense
4082000
Annuals > 2 > income Statement > pretax Income
-91000
Annuals > 2 > income Statement > net Income
152000
Annuals > 2 > income Statement > eps
0.0018857250612860645
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
80605600
Annuals > 2 > income Statement > income Tax Expense
-243000
Annuals > 2 > income Statement > EBITDA
-67596000
Annuals > 2 > income Statement > operating Margin
-32.458026877057065
Annuals > 2 > income Statement > total Other Income Expense Net
81860000
Annuals > 2 > balance Sheet > cash
14010000
Annuals > 2 > balance Sheet > short Term Investments
59796000
Annuals > 2 > balance Sheet > receivables
40433000
Annuals > 2 > balance Sheet > inventories
9261000
Annuals > 2 > balance Sheet > total Current Assets
130418000
Annuals > 2 > balance Sheet > property Plant Equipment
33041000
Annuals > 2 > balance Sheet > total Assets
261665000
Annuals > 2 > balance Sheet > payables
9372000
Annuals > 2 > balance Sheet > short Term Debt
5498000
Annuals > 2 > balance Sheet > long Term Debt
80621000
Annuals > 2 > balance Sheet > total Liabilities
138490000
Annuals > 2 > balance Sheet > equity
123175000
Annuals > 2 > cash Flow > net Income
152000
Annuals > 2 > cash Flow > depreciation
4411000
Annuals > 2 > cash Flow > change In Working Capital
-20541000
Annuals > 2 > cash Flow > cash From Operations
-61756000
Annuals > 2 > cash Flow > capital Expenditures
5529000
Annuals > 2 > cash Flow > cash From Investing
-131614000
Annuals > 2 > cash Flow > cash From Financing
92206000
Annuals > 2 > cash Flow > net Change In Cash
-101164000
Annuals > 2 > ratios > PE
0.0018857250612860645
Annuals > 2 > ratios > PB
2.009005009133347
Annuals > 2 > ratios > ROE
0.12340166429876193
Annuals > 2 > ratios > ROA
0.058089541971604916
Annuals > 2 > ratios > FCF
-67285000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.2664931896404906
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
203003000
Annuals > 3 > income Statement > cost Of Revenue
162155000
Annuals > 3 > income Statement > gross Profit
40848000
Annuals > 3 > income Statement > operating Expenses
86706000
Annuals > 3 > income Statement > operating Income
-45858000
Annuals > 3 > income Statement > interest Expense
320000
Annuals > 3 > income Statement > pretax Income
-11598000
Annuals > 3 > income Statement > net Income
-10927000
Annuals > 3 > income Statement > eps
-0.16498414894443436
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
66230605
Annuals > 3 > income Statement > income Tax Expense
-671000
Annuals > 3 > income Statement > EBITDA
-42041000
Annuals > 3 > income Statement > operating Margin
-22.5898139436363
Annuals > 3 > income Statement > total Other Income Expense Net
34260000
Annuals > 3 > balance Sheet > cash
114299000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
21244000
Annuals > 3 > balance Sheet > inventories
6438000
Annuals > 3 > balance Sheet > total Current Assets
154056000
Annuals > 3 > balance Sheet > property Plant Equipment
4192000
Annuals > 3 > balance Sheet > total Assets
203439000
Annuals > 3 > balance Sheet > payables
15559000
Annuals > 3 > balance Sheet > short Term Debt
183000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
99280000
Annuals > 3 > balance Sheet > equity
104159000
Annuals > 3 > cash Flow > net Income
-10927000
Annuals > 3 > cash Flow > depreciation
3341000
Annuals > 3 > cash Flow > change In Working Capital
-14489000
Annuals > 3 > cash Flow > cash From Operations
-32680000
Annuals > 3 > cash Flow > capital Expenditures
3047000
Annuals > 3 > cash Flow > cash From Investing
-12154000
Annuals > 3 > cash Flow > cash From Financing
154010000
Annuals > 3 > cash Flow > net Change In Cash
109176000
Annuals > 3 > ratios > PE
-0.16498414894443436
Annuals > 3 > ratios > PB
1.9520920645359496
Annuals > 3 > ratios > ROE
-10.490692114939659
Annuals > 3 > ratios > ROA
-5.371143192799807
Annuals > 3 > ratios > FCF
-35727000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.17599247301764012
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.016931556164205195
Valuation > metrics > PB
-300.1912438161968
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
134.46309271631088
Profitability > metrics > ROA
-14.99109835410384
Profitability > metrics > Net Margin
-0.12085176181131191
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.194791666666666
Risk > final Score
13
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.5725435214394206
Liquidity > metrics > Quick Ratio
2.1313237527748568
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
6
Prev Risks > 1
-1
Prev Risks > 2
-35
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:19:09.704Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0767
Earnings History > 0 > eps Difference
0.0767
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.14
Earnings History > 1 > eps Estimate
-0.11
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-27.2727
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.15
Earnings History > 2 > eps Estimate
-0.12
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-25
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2085
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.143
Earnings History > 4 > eps Estimate
-0.08
Earnings History > 4 > eps Difference
-0.063
Earnings History > 4 > surprise Percent
-78.75
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.1751
Earnings History > 5 > eps Estimate
-0.06
Earnings History > 5 > eps Difference
-0.1151
Earnings History > 5 > surprise Percent
-191.8333
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.17
Earnings History > 6 > eps Estimate
-0.1
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-70
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.22
Earnings History > 7 > eps Estimate
-0.12
Earnings History > 7 > eps Difference
-0.1
Earnings History > 7 > surprise Percent
-83.3333
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.21
Earnings History > 8 > eps Estimate
-0.11
Earnings History > 8 > eps Difference
-0.1
Earnings History > 8 > surprise Percent
-90.9091
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-08
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.19
Earnings History > 9 > eps Estimate
-0.13
Earnings History > 9 > eps Difference
-0.06
Earnings History > 9 > surprise Percent
-46.1538
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.19
Earnings History > 10 > eps Estimate
-0.17
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-11.7647
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.33
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
-0.16
Earnings History > 11 > surprise Percent
-94.1176
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.25
Earnings History > 12 > eps Estimate
-0.18
Earnings History > 12 > eps Difference
-0.07
Earnings History > 12 > surprise Percent
-38.8889
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.25
Earnings History > 13 > eps Estimate
-0.18
Earnings History > 13 > eps Difference
-0.07
Earnings History > 13 > surprise Percent
-38.8889
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.09
Earnings History > 14 > eps Estimate
-0.11
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
18.1818
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.25
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-11
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.14
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-08
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.02
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.21
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-28
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.2
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-30
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.01
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-13
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0048
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-13
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.004
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-08
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 36.36% of the total shares of Oncology Institute Inc
1.
Vanguard Group Inc(4.5783%)
since
2025/06/30
2.
TIFF Advisory Services Inc(3.8869%)
since
2025/06/30
3.
Deerfield Management Co(3.5935%)
since
2025/06/30
4.
BlackRock Inc(3.5366%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(3.0415%)
since
2025/07/31
6.
Balyasny Asset Management LLC(2.6933%)
since
2025/06/30
7.
Marshall Wace Asset Management Ltd(1.5795%)
since
2025/06/30
8.
iShares Russell 2000 ETF(1.5708%)
since
2025/08/31
9.
Geode Capital Management, LLC(1.3683%)
since
2025/06/30
10.
Wexford Capital LP(1.1964%)
since
2025/06/30
11.
CenterBook Partners LP(0.7656%)
since
2025/06/30
12.
State Street Corp(0.6911%)
since
2025/06/30
13.
Fidelity Small Cap Index(0.6332%)
since
2025/06/30
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.5849%)
since
2025/07/31
15.
iShares Russell 2000 Growth ETF(0.5457%)
since
2025/08/31
16.
Renaissance Technologies Corp(0.4893%)
since
2025/06/30
17.
UBS Group AG(0.4496%)
since
2025/06/30
18.
Northern Trust Corp(0.4399%)
since
2025/06/30
19.
Millennium Management LLC(0.4331%)
since
2025/06/30
20.
FourWorld Capital Management LLC(0.4189%)
since
2025/06/30
21.
Freegulliver, LLC(0.3677%)
since
2025/06/30
22.
JOSH ARNOLD INVESTMENT CONSULTANT, LLC(0.3114%)
since
2025/06/30
23.
Vanguard Russell 2000 ETF(0.3013%)
since
2025/07/31
24.
Two Sigma Investments LLC(0.2975%)
since
2025/06/30
25.
Fidelity Extended Market Index(0.285%)
since
2025/07/31
26.
Manatuck Hill Partners LLC(0.2672%)
since
2025/06/30
27.
Bank of New York Mellon Corp(0.2659%)
since
2025/06/30
28.
State St Russell Sm Cap® Indx SL Cl I(0.2228%)
since
2025/08/31
29.
IMC US Ultra Micro Cap(0.1738%)
since
2025/07/31
30.
Schwab Small Cap Index(0.1578%)
since
2025/07/31
31.
NT R2000 Index Fund - NL(0.1527%)
since
2025/06/30
32.
Strategic Advisers U.S. Total Stock(0.1445%)
since
2025/07/31
33.
iShares Micro-Cap ETF(0.1428%)
since
2025/08/31
34.
NT R2000 Index Fund - DC - NL - 3(0.1217%)
since
2025/06/30
35.
Extended Equity Market Fund K(0.119%)
since
2025/06/30
36.
SPDR® Russell 2000 US Small Cap ETF(0.1133%)
since
2025/08/31
37.
Pleiades Small Cap Equity A(0.1118%)
since
2025/06/30
38.
iShares Russell 2000 Small-Cap Idx Instl(0.1094%)
since
2025/07/31
39.
Russell 2500™ Index Fund F(0.0994%)
since
2025/06/30
40.
Fidelity Total Market Index(0.0964%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0767
Date
2025-09-30
EPS Actual
-0.14
EPS Estimate
-0.11
EPS Difference
-0.03
Surprise Percent
-27.2727%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.